Is guideline-adherent adjuvant treatment an equal alternative for patients aged >65 who cannot participate in adjuvant clinical breast cancer trials? A retrospective multi-center cohort study of 4,142 patients
Crossref DOI link: https://doi.org/10.1007/s00404-014-3438-7
Published Online: 2014-09-02
Published Print: 2015-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Van Ewijk, R.
Wöckel, A.
Gundelach, T.
Hancke, K.
Janni, W.
Singer, S.
Kreienberg, R.
Blettner, M.
Schwentner, L.
Text and Data Mining valid from 2014-09-02